Altabax Related Published Studies
Well-designed clinical trials related to Altabax (Retapamulin)
The safety and efficacy of topical retapamulin ointment versus placebo ointment
in the treatment of secondarily infected traumatic lesions: a randomized,
double-blind superiority study. [2013]
Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial. [2008.05]
Topical retapamulin ointment, 1%, versus sodium fusidate ointment, 2%, for impetigo: a randomized, observer-blinded, noninferiority study. [2007]
Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial. [2006.12]
Retapamulin ointment twice daily for 5 days vs oral cephalexin twice daily for 10 days for empiric treatment of secondarily infected traumatic lesions of the skin. [2006.09]
Other research related to Altabax (Retapamulin)
Retapamulin: what is the role of this topical antimicrobial in the treatment of bacterial infections in atopic dermatitis? [2010.01]
Microbiological profile of a new topical antibacterial: retapamulin ointment 1%. [2009.04]
Proposed MIC and disk diffusion microbiological cutoffs and spectrum of activity of retapamulin, a novel topical antimicrobial agent. [2008.11]
Retapamulin: a new topical antibiotic for the treatment of uncomplicated skin infections. [2008.02]
Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections. [2008]
Spotlight on retapamulin in impetigo and other uncomplicated superficial skin infections. [2008]
Retapamulin: a semisynthetic pleuromutilin compound for topical treatment of skin infections in adults and children. [2007.12]
Use of the surgical wound infection model to determine the efficacious dosing regimen of retapamulin, a novel topical antibiotic. [2006.11]
Other possibly related research studies
A primer on topical antibiotics for the skin and eyes. [2008.04]
Gateways to clinical trials. [2007.06]
Gateways to clinical trials. [2007.05]
Gateways to clinical trials. [2006.10]
Local antibiotics in dermatology. [2008.05]
Agents for the decolonization of methicillin-resistant Staphylococcus aureus. [2009.03]
[Pediatric dermatology. New aspects of bacterial skin infections in children] [2009.03]
The pleuromutilin antibiotics: a new class for human use. [2010.02]
Lost in translation: differences in antimicrobial indication approval policies between the United States and Europe. [2009.07]
[Introduction to cutaneous bacterial infections] [2007.09]
Nonhealing scalp wound infected with Aspergillus niger in an elderly patient. [2011.04]
Interventions for impetigo. [2012]
|